We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current APGE market cap is 2.22B. The company's latest EPS is USD -1.4367 and P/E is -26.40.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|
| USD (US$) | |||
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -24.31M | -42.6M | -38.18M |
| Net Income | -20.84M | -31.74M | -32.09M |
| Year End 31 December 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Revenue | 0 |
| Operating Income | -93M |
| Net Income | -83.99M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|
| USD (US$) | |||
| Total Assets | 426.42M | 401.4M | 823.66M |
| Total Liabilities | 17.18M | 21.49M | 22.18M |
| Total Equity | 409.24M | 379.91M | 801.48M |
| Year End 31 December 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Assets | 401.4M |
| Total Liabilities | 21.49M |
| Total Equity | 379.91M |
| Market Cap | 2.22B |
| Price to Earnings Ratio | -26.40 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 18.74 |
| Price to Book Ratio | 5.84 |
| Dividend Yield | - |
| Shares Outstanding | 58.46M |
| Average Volume (1 week) | 659.39k |
| Average Volume (1 Month) | 419.16k |
| 52 Week Change | 76.74% |
| 52 Week High | 72.29 |
| 52 Week Low | 14.19 |
| Spread (Intraday) | 32.1 (47.84%) |
| Company Name | Apogee Therapeutics Inc |
| Address |
1209 orange st wilmington, delaware 19801 |
| Website | https://www.apogeetherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
